Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | PGR | P06401 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.49 |
| ▸ | PDE4A | P27815 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | SNCA | P37840 | 1/20 | 0.49 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.48 |
| ▸ | ICMT | O60725 | 1/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2289564 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL27407686 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL28575111 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL6463435 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL2236562 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL6028170 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL14759154 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL1071266 | 0.98 | MAPT (0.47) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL1071264 | 0.98 | MAPT (0.47) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL16653887 | 0.98 | MAPT (0.47) | MAPTPGRHTR1AADORA3PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9371301-B2 | Prenylarene compound and use thereof | OSAKA UNIVERSITY (JP) | 2016-06-21 | — | — | US | disclosed |
| US-20130065937-A1 | NOVEL PRENYLARENE COMPOUND AND USE THEREOF | OSAKA UNIVERSITY (JP) | 2013-03-14 | — | — | US | disclosed |
| EP-2567956-A1 | NOVEL PRENYLARENE COMPOUND AND USE THEREOF | Osaka University (JP) | 2013-03-13 | — | — | EP | disclosed |
| EP-0771778-B1 | Process for producing all trans-form polyprenols | KURARAY CO (JP) | 2001-01-10 | — | — | EP | disclosed |
| EP-1031551-A2 | A process for preparing all trans-form polyprenols | KURARAY CO., LTD. (JP) | 2000-08-30 | — | — | EP | disclosed |
| US-5714645-A | LENGTHENING 3,7-DIMETHYL-6-HYDROXY=7-OCTEN-1-OL BY REACTING WITH 2-METHYL-3,3-DIMETHOXY-1-BUTENE; REDUCING THE CARBONYL; HALOGENATING THE ALLYLHYDROXY; REACTING WITH A POLYISOPRENYL SULFONE AND DESULFONATING | KURARAY CO., LTD. (JP) | 1998-02-03 | — | — | US | disclosed |
| EP-0771778-A2 | Process for producing all trans-form polyprenols | KURARAY CO., LTD. (JP) | 1997-05-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065937-A1 | NOVEL PRENYLARENE COMPOUND AND USE THEREOF | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NR1H3, HIF1AN | MAPT 4854/4885PGR 737/4885HTR1A 3149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.